Status:

NOT_YET_RECRUITING

Screening of Predictive Biomarkers for Cardiorenal Syndrome

Lead Sponsor:

Haiyan Pan

Conditions:

Cardiorenal Syndrome (CRS)

Eligibility:

All Genders

18-75 years

Brief Summary

This study aims to explore the predictive value of specific biomarkers for cardiorenal syndrome (CRS) in patients with chronic heart failure (CHF). Building on previous research using Luminex technol...

Detailed Description

This study is a prospective observational cohort study designed to screen and validate the predictive value of five serum biomarkers (secretory leukocyte protease inhibitor \[SLPI\], Serpin E1, C-X-C ...

Eligibility Criteria

Inclusion

  • Adults aged 18 to 75 years.
  • Diagnosed with stable chronic heart failure (HF) according to the 2024 Chinese Heart Failure Diagnosis and Treatment Guideline.
  • HF subtypes include:
  • HFrEF (LVEF ≤40%), HFmrEF (LVEF 41 - 49%), HFpEF (LVEF ≥50%).
  • Willing to provide blood samples for biomarker analysis.
  • Able to comply with follow - up visits and study procedures for 12 months.
  • Note: For the screening phase, 10 patients will be included for each subtype; for the validation phase, 30 patients will be included for each subtype.

Exclusion

  • History of long-term dialysis or kidney surgery.
  • Acute kidney injury (AKI) within the past 3 months.
  • Use of nephrotoxic drugs within the past 3 months.
  • Diagnosis of autoimmune diseases (e.g., lupus, rheumatoid arthritis).
  • Active malignancy or history of cancer treatment within the past 5 years.
  • Acute infectious diseases at the time of enrollment.
  • Severe liver dysfunction (e.g., cirrhosis, ALT/AST \>3× upper limit of normal).
  • Pregnancy or lactation.
  • Inability or unwillingness to provide informed consent.
  • Participation in another interventional clinical trial within the past 30 days.

Key Trial Info

Start Date :

September 15 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT07139626

Start Date

September 15 2025

End Date

December 31 2027

Last Update

September 8 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.